According to CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles-PubMed (2022), Beier et al. (2008), several stem cell types exhibit different MGMT protein expressions despite having equivalent MGMT promoter methylation status. This evidence concerns the gene MGMT and cancer.